Global CAR T-Cell Therapy Market Research Report 2026(Status and Outlook)
CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is an innovative form of immunotherapy that involves genetically modifying a patient?s own T cells to express a specific chimeric antigen receptor (CAR) on their surface. This receptor enables the T cells to target and destroy cancer cells effectively. CAR-T therapy has shown significant success in treating hematological malignancies, such as acute lymphoblastic leukemia (ALL) and certain types of lymphomas, and is being explored for its potential applications in solid tumors.The CAR-T Cell Therapy market is primarily driven by its groundbreaking effectiveness in treating certain types of hematological malignancies, such as acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), particularly in patients who are refractory to standard treatments. The rising incidence of cancer globally and the growing demand for personalized and targeted therapies have further fueled market growth. In addition, advancements in genetic engineering and manufacturing processes are making CAR-T therapies safer, more efficient, and increasingly accessible. The strong support from government initiatives and private investments in oncology research is also accelerating the development of next-generation CAR-T products, expanding their therapeutic potential to include solid tumors.However, the market faces significant challenges, including the high cost of CAR-T therapies, which can exceed hundreds of thousands of dollars per treatment, making it inaccessible to many patients. The complex and time-consuming manufacturing process, which involves extracting and engineering a patient?s T cells, further contributes to these high costs. Additionally, CAR-T therapy is associated with severe side effects, such as cytokine release syndrome (CRS) and neurotoxicity, which require specialized management and can limit its broader adoption. Regulatory hurdles and the need for improved scalability also present obstacles, particularly in developing regions where healthcare infrastructure may be inadequate to support this advanced therapy.
The global CAR T-Cell Therapy market size was estimated at USD 5417.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 26.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CAR T-Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CAR T-Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CAR T-Cell Therapy market.
Global CAR T-Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Market Segmentation (by Type)
CD19 - Targeted
BCMA - Targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell Therapy Market
Overview of the regional outlook of the CAR T-Cell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CAR T-Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global CAR T-Cell Therapy market size was estimated at USD 5417.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 26.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CAR T-Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CAR T-Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CAR T-Cell Therapy market.
Global CAR T-Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Market Segmentation (by Type)
CD19 - Targeted
BCMA - Targeted
Market Segmentation (by Application)
Lymphoma
Multiple Myeloma
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CAR T-Cell Therapy Market
Overview of the regional outlook of the CAR T-Cell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CAR T-Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy
1.2 Key Market Segments
1.2.1 CAR T-Cell Therapy Segment by Type
1.2.2 CAR T-Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CAR T-Cell Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CAR T-Cell Therapy Product Life Cycle
3.3 Global CAR T-Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global CAR T-Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CAR T-Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CAR T-Cell Therapy Market Competitive Situation and Trends
3.8.1 CAR T-Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest CAR T-Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CAR T-Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CAR T-Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 CAR T-CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global CAR T-Cell Therapy Market Size by Type (2020-2025)
6.4 Global CAR T-Cell Therapy Price by Type (2020-2025)
7 CAR T-CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell Therapy Market Sales by Application (2020-2025)
7.3 Global CAR T-Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global CAR T-Cell Therapy Sales Growth Rate by Application (2020-2025)
8 CAR T-CELL THERAPY MARKET SALES BY REGION
8.1 Global CAR T-Cell Therapy Sales by Region
8.1.1 Global CAR T-Cell Therapy Sales by Region
8.1.2 Global CAR T-Cell Therapy Sales Market Share by Region
8.2 Global CAR T-Cell Therapy Market Size by Region
8.2.1 Global CAR T-Cell Therapy Market Size by Region
8.2.2 Global CAR T-Cell Therapy Market Size by Region
8.3 North America
8.3.1 North America CAR T-Cell Therapy Sales by Country
8.3.2 North America CAR T-Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CAR T-Cell Therapy Sales by Country
8.4.2 Europe CAR T-Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CAR T-Cell Therapy Sales by Region
8.5.2 Asia Pacific CAR T-Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CAR T-Cell Therapy Sales by Country
8.6.2 South America CAR T-Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CAR T-Cell Therapy Sales by Region
8.7.2 Middle East and Africa CAR T-Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CAR T-CELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of CAR T-Cell Therapy by Region(2020-2025)
9.2 Global CAR T-Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CAR T-Cell Therapy Production
9.4.1 North America CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CAR T-Cell Therapy Production
9.5.1 Europe CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CAR T-Cell Therapy Production (2020-2025)
9.6.1 Japan CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CAR T-Cell Therapy Production (2020-2025)
9.7.1 China CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis CAR T-Cell Therapy Product Overview
10.1.3 Novartis CAR T-Cell Therapy Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences CAR T-Cell Therapy Product Overview
10.2.3 Gilead Sciences CAR T-Cell Therapy Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J CAR T-Cell Therapy Product Overview
10.4.3 J and J CAR T-Cell Therapy Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics CAR T-Cell Therapy Product Overview
10.5.3 JW Therapeutics CAR T-Cell Therapy Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite CAR T-Cell Therapy Product Overview
10.6.3 FOSUNKite CAR T-Cell Therapy Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 Autolus Therapeutics(Pipeline)
10.8.1 Autolus Therapeutics(Pipeline) Basic Information
10.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
10.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Market Performance
10.8.4 Autolus Therapeutics(Pipeline) Business Overview
10.8.5 Autolus Therapeutics(Pipeline) Recent Developments
10.9 Sorrento Therapeutics(Pipeline)
10.9.1 Sorrento Therapeutics(Pipeline) Basic Information
10.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
10.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Market Performance
10.9.4 Sorrento Therapeutics(Pipeline) Business Overview
10.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
10.10 Mustang Bio(Pipeline)
10.10.1 Mustang Bio(Pipeline) Basic Information
10.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Overview
10.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Market Performance
10.10.4 Mustang Bio(Pipeline) Business Overview
10.10.5 Mustang Bio(Pipeline) Recent Developments
10.11 Bluebird Bio(Pipeline)
10.11.1 Bluebird Bio(Pipeline) Basic Information
10.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Overview
10.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Market Performance
10.11.4 Bluebird Bio(Pipeline) Business Overview
10.11.5 Bluebird Bio(Pipeline) Recent Developments
10.12 Cellectis(Pipeline)
10.12.1 Cellectis(Pipeline) Basic Information
10.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Overview
10.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Product Market Performance
10.12.4 Cellectis(Pipeline) Business Overview
10.12.5 Cellectis(Pipeline) Recent Developments
10.13 Allogene Therapeutics(Pipeline)
10.13.1 Allogene Therapeutics(Pipeline) Basic Information
10.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
10.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Market Performance
10.13.4 Allogene Therapeutics(Pipeline) Business Overview
10.13.5 Allogene Therapeutics(Pipeline) Recent Developments
10.14 Celyad(Pipeline)
10.14.1 Celyad(Pipeline) Basic Information
10.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Overview
10.14.3 Celyad(Pipeline) CAR T-Cell Therapy Product Market Performance
10.14.4 Celyad(Pipeline) Business Overview
10.14.5 Celyad(Pipeline) Recent Developments
11 CAR T-CELL THERAPY MARKET FORECAST BY REGION
11.1 Global CAR T-Cell Therapy Market Size Forecast
11.2 Global CAR T-Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CAR T-Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific CAR T-Cell Therapy Market Size Forecast by Region
11.2.4 South America CAR T-Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CAR T-Cell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CAR T-Cell Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CAR T-Cell Therapy by Type (2026-2035)
12.1.2 Global CAR T-Cell Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CAR T-Cell Therapy by Type (2026-2035)
12.2 Global CAR T-Cell Therapy Market Forecast by Application (2026-2035)
12.2.1 Global CAR T-Cell Therapy Sales (K MT) Forecast by Application
12.2.2 Global CAR T-Cell Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CAR T-Cell Therapy
1.2 Key Market Segments
1.2.1 CAR T-Cell Therapy Segment by Type
1.2.2 CAR T-Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CAR T-CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CAR T-Cell Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CAR T-CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CAR T-Cell Therapy Product Life Cycle
3.3 Global CAR T-Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global CAR T-Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CAR T-Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CAR T-Cell Therapy Market Competitive Situation and Trends
3.8.1 CAR T-Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest CAR T-Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CAR T-CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 CAR T-Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CAR T-Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CAR T-Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 CAR T-CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global CAR T-Cell Therapy Market Size by Type (2020-2025)
6.4 Global CAR T-Cell Therapy Price by Type (2020-2025)
7 CAR T-CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell Therapy Market Sales by Application (2020-2025)
7.3 Global CAR T-Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global CAR T-Cell Therapy Sales Growth Rate by Application (2020-2025)
8 CAR T-CELL THERAPY MARKET SALES BY REGION
8.1 Global CAR T-Cell Therapy Sales by Region
8.1.1 Global CAR T-Cell Therapy Sales by Region
8.1.2 Global CAR T-Cell Therapy Sales Market Share by Region
8.2 Global CAR T-Cell Therapy Market Size by Region
8.2.1 Global CAR T-Cell Therapy Market Size by Region
8.2.2 Global CAR T-Cell Therapy Market Size by Region
8.3 North America
8.3.1 North America CAR T-Cell Therapy Sales by Country
8.3.2 North America CAR T-Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CAR T-Cell Therapy Sales by Country
8.4.2 Europe CAR T-Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CAR T-Cell Therapy Sales by Region
8.5.2 Asia Pacific CAR T-Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CAR T-Cell Therapy Sales by Country
8.6.2 South America CAR T-Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CAR T-Cell Therapy Sales by Region
8.7.2 Middle East and Africa CAR T-Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CAR T-CELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of CAR T-Cell Therapy by Region(2020-2025)
9.2 Global CAR T-Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CAR T-Cell Therapy Production
9.4.1 North America CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CAR T-Cell Therapy Production
9.5.1 Europe CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CAR T-Cell Therapy Production (2020-2025)
9.6.1 Japan CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CAR T-Cell Therapy Production (2020-2025)
9.7.1 China CAR T-Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China CAR T-Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis CAR T-Cell Therapy Product Overview
10.1.3 Novartis CAR T-Cell Therapy Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Basic Information
10.2.2 Gilead Sciences CAR T-Cell Therapy Product Overview
10.2.3 Gilead Sciences CAR T-Cell Therapy Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Basic Information
10.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Overview
10.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Business Overview
10.3.5 Bristol-Myers Squibb SWOT Analysis
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Basic Information
10.4.2 J and J CAR T-Cell Therapy Product Overview
10.4.3 J and J CAR T-Cell Therapy Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Basic Information
10.5.2 JW Therapeutics CAR T-Cell Therapy Product Overview
10.5.3 JW Therapeutics CAR T-Cell Therapy Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Basic Information
10.6.2 FOSUNKite CAR T-Cell Therapy Product Overview
10.6.3 FOSUNKite CAR T-Cell Therapy Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 Autolus Therapeutics(Pipeline)
10.8.1 Autolus Therapeutics(Pipeline) Basic Information
10.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
10.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Market Performance
10.8.4 Autolus Therapeutics(Pipeline) Business Overview
10.8.5 Autolus Therapeutics(Pipeline) Recent Developments
10.9 Sorrento Therapeutics(Pipeline)
10.9.1 Sorrento Therapeutics(Pipeline) Basic Information
10.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
10.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Market Performance
10.9.4 Sorrento Therapeutics(Pipeline) Business Overview
10.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
10.10 Mustang Bio(Pipeline)
10.10.1 Mustang Bio(Pipeline) Basic Information
10.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Overview
10.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Market Performance
10.10.4 Mustang Bio(Pipeline) Business Overview
10.10.5 Mustang Bio(Pipeline) Recent Developments
10.11 Bluebird Bio(Pipeline)
10.11.1 Bluebird Bio(Pipeline) Basic Information
10.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Overview
10.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Market Performance
10.11.4 Bluebird Bio(Pipeline) Business Overview
10.11.5 Bluebird Bio(Pipeline) Recent Developments
10.12 Cellectis(Pipeline)
10.12.1 Cellectis(Pipeline) Basic Information
10.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Overview
10.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Product Market Performance
10.12.4 Cellectis(Pipeline) Business Overview
10.12.5 Cellectis(Pipeline) Recent Developments
10.13 Allogene Therapeutics(Pipeline)
10.13.1 Allogene Therapeutics(Pipeline) Basic Information
10.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
10.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Market Performance
10.13.4 Allogene Therapeutics(Pipeline) Business Overview
10.13.5 Allogene Therapeutics(Pipeline) Recent Developments
10.14 Celyad(Pipeline)
10.14.1 Celyad(Pipeline) Basic Information
10.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Overview
10.14.3 Celyad(Pipeline) CAR T-Cell Therapy Product Market Performance
10.14.4 Celyad(Pipeline) Business Overview
10.14.5 Celyad(Pipeline) Recent Developments
11 CAR T-CELL THERAPY MARKET FORECAST BY REGION
11.1 Global CAR T-Cell Therapy Market Size Forecast
11.2 Global CAR T-Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CAR T-Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific CAR T-Cell Therapy Market Size Forecast by Region
11.2.4 South America CAR T-Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CAR T-Cell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CAR T-Cell Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CAR T-Cell Therapy by Type (2026-2035)
12.1.2 Global CAR T-Cell Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CAR T-Cell Therapy by Type (2026-2035)
12.2 Global CAR T-Cell Therapy Market Forecast by Application (2026-2035)
12.2.1 Global CAR T-Cell Therapy Sales (K MT) Forecast by Application
12.2.2 Global CAR T-Cell Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CAR T-Cell Therapy Market Size by Type (M USD)
Table 4. Global CAR T-Cell Therapy Market Size by Application
Table 5. CAR T-Cell Therapy Market Size Comparison by Region (M USD)
Table 6. Global CAR T-Cell Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CAR T-Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CAR T-Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CAR T-Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2025)
Table 11. Global Market CAR T-Cell Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CAR T-Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CAR T-Cell Therapy Sales by Type (K MT)
Table 27. Global CAR T-Cell Therapy Market Size by Type (M USD)
Table 28. Global CAR T-Cell Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global CAR T-Cell Therapy Sales Market Share by Type (2020-2025)
Table 30. Global CAR T-Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global CAR T-Cell Therapy Market Share by Type (2020-2025)
Table 32. Global CAR T-Cell Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global CAR T-Cell Therapy Sales (K MT) by Application
Table 34. Global CAR T-Cell Therapy Market Size by Application
Table 35. Global CAR T-Cell Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global CAR T-Cell Therapy Sales Market Share by Application (2020-2025)
Table 37. Global CAR T-Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global CAR T-Cell Therapy Market Share by Application (2020-2025)
Table 39. Global CAR T-Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global CAR T-Cell Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global CAR T-Cell Therapy Sales Market Share by Region (2020-2025)
Table 42. Global CAR T-Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global CAR T-Cell Therapy Market Size by Region (2020-2025)
Table 44. North America CAR T-Cell Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America CAR T-Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CAR T-Cell Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe CAR T-Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CAR T-Cell Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CAR T-Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America CAR T-Cell Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America CAR T-Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CAR T-Cell Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CAR T-Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global CAR T-Cell Therapy Production (K MT) by Region(2020-2025)
Table 55. Global CAR T-Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CAR T-Cell Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis CAR T-Cell Therapy Product Overview
Table 64. Novartis CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences CAR T-Cell Therapy Product Overview
Table 70. Gilead Sciences CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb CAR T-Cell Therapy Product Overview
Table 76. Bristol-Myers Squibb CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J CAR T-Cell Therapy Product Overview
Table 82. J and J CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics CAR T-Cell Therapy Product Overview
Table 87. JW Therapeutics CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite CAR T-Cell Therapy Product Overview
Table 92. FOSUNKite CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics (Pipeline) Basic Information
Table 96. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Overview
Table 97. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics (Pipeline) Business Overview
Table 99. CARsgen Therapeutics (Pipeline) Recent Developments
Table 100. Autolus Therapeutics(Pipeline) Basic Information
Table 101. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
Table 102. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Autolus Therapeutics(Pipeline) Business Overview
Table 104. Autolus Therapeutics(Pipeline) Recent Developments
Table 105. Sorrento Therapeutics(Pipeline) Basic Information
Table 106. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
Table 107. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics(Pipeline) Business Overview
Table 109. Sorrento Therapeutics(Pipeline) Recent Developments
Table 110. Mustang Bio(Pipeline) Basic Information
Table 111. Mustang Bio(Pipeline) CAR T-Cell Therapy Product Overview
Table 112. Mustang Bio(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mustang Bio(Pipeline) Business Overview
Table 114. Mustang Bio(Pipeline) Recent Developments
Table 115. Bluebird Bio(Pipeline) Basic Information
Table 116. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Overview
Table 117. Bluebird Bio(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Bluebird Bio(Pipeline) Business Overview
Table 119. Bluebird Bio(Pipeline) Recent Developments
Table 120. Cellectis(Pipeline) Basic Information
Table 121. Cellectis(Pipeline) CAR T-Cell Therapy Product Overview
Table 122. Cellectis(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Cellectis(Pipeline) Business Overview
Table 124. Cellectis(Pipeline) Recent Developments
Table 125. Allogene Therapeutics(Pipeline) Basic Information
Table 126. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
Table 127. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics(Pipeline) Business Overview
Table 129. Allogene Therapeutics(Pipeline) Recent Developments
Table 130. Celyad(Pipeline) Basic Information
Table 131. Celyad(Pipeline) CAR T-Cell Therapy Product Overview
Table 132. Celyad(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Celyad(Pipeline) Business Overview
Table 134. Celyad(Pipeline) Recent Developments
Table 135. Global CAR T-Cell Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global CAR T-Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific CAR T-Cell Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific CAR T-Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global CAR T-Cell Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global CAR T-Cell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global CAR T-Cell Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global CAR T-Cell Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global CAR T-Cell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CAR T-Cell Therapy Market Size by Type (M USD)
Table 4. Global CAR T-Cell Therapy Market Size by Application
Table 5. CAR T-Cell Therapy Market Size Comparison by Region (M USD)
Table 6. Global CAR T-Cell Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CAR T-Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CAR T-Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CAR T-Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2025)
Table 11. Global Market CAR T-Cell Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CAR T-Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CAR T-Cell Therapy Sales by Type (K MT)
Table 27. Global CAR T-Cell Therapy Market Size by Type (M USD)
Table 28. Global CAR T-Cell Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global CAR T-Cell Therapy Sales Market Share by Type (2020-2025)
Table 30. Global CAR T-Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global CAR T-Cell Therapy Market Share by Type (2020-2025)
Table 32. Global CAR T-Cell Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global CAR T-Cell Therapy Sales (K MT) by Application
Table 34. Global CAR T-Cell Therapy Market Size by Application
Table 35. Global CAR T-Cell Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global CAR T-Cell Therapy Sales Market Share by Application (2020-2025)
Table 37. Global CAR T-Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global CAR T-Cell Therapy Market Share by Application (2020-2025)
Table 39. Global CAR T-Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global CAR T-Cell Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global CAR T-Cell Therapy Sales Market Share by Region (2020-2025)
Table 42. Global CAR T-Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global CAR T-Cell Therapy Market Size by Region (2020-2025)
Table 44. North America CAR T-Cell Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America CAR T-Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CAR T-Cell Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe CAR T-Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CAR T-Cell Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CAR T-Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America CAR T-Cell Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America CAR T-Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CAR T-Cell Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CAR T-Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global CAR T-Cell Therapy Production (K MT) by Region(2020-2025)
Table 55. Global CAR T-Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CAR T-Cell Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CAR T-Cell Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis CAR T-Cell Therapy Product Overview
Table 64. Novartis CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Basic Information
Table 69. Gilead Sciences CAR T-Cell Therapy Product Overview
Table 70. Gilead Sciences CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Gilead Sciences Business Overview
Table 72. Gilead Sciences SWOT Analysis
Table 73. Gilead Sciences Recent Developments
Table 74. Bristol-Myers Squibb Basic Information
Table 75. Bristol-Myers Squibb CAR T-Cell Therapy Product Overview
Table 76. Bristol-Myers Squibb CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Business Overview
Table 78. Bristol-Myers Squibb SWOT Analysis
Table 79. Bristol-Myers Squibb Recent Developments
Table 80. J and J Basic Information
Table 81. J and J CAR T-Cell Therapy Product Overview
Table 82. J and J CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. J and J Business Overview
Table 84. J and J Recent Developments
Table 85. JW Therapeutics Basic Information
Table 86. JW Therapeutics CAR T-Cell Therapy Product Overview
Table 87. JW Therapeutics CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. JW Therapeutics Business Overview
Table 89. JW Therapeutics Recent Developments
Table 90. FOSUNKite Basic Information
Table 91. FOSUNKite CAR T-Cell Therapy Product Overview
Table 92. FOSUNKite CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. FOSUNKite Business Overview
Table 94. FOSUNKite Recent Developments
Table 95. CARsgen Therapeutics (Pipeline) Basic Information
Table 96. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Overview
Table 97. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics (Pipeline) Business Overview
Table 99. CARsgen Therapeutics (Pipeline) Recent Developments
Table 100. Autolus Therapeutics(Pipeline) Basic Information
Table 101. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
Table 102. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Autolus Therapeutics(Pipeline) Business Overview
Table 104. Autolus Therapeutics(Pipeline) Recent Developments
Table 105. Sorrento Therapeutics(Pipeline) Basic Information
Table 106. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
Table 107. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics(Pipeline) Business Overview
Table 109. Sorrento Therapeutics(Pipeline) Recent Developments
Table 110. Mustang Bio(Pipeline) Basic Information
Table 111. Mustang Bio(Pipeline) CAR T-Cell Therapy Product Overview
Table 112. Mustang Bio(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Mustang Bio(Pipeline) Business Overview
Table 114. Mustang Bio(Pipeline) Recent Developments
Table 115. Bluebird Bio(Pipeline) Basic Information
Table 116. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Overview
Table 117. Bluebird Bio(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Bluebird Bio(Pipeline) Business Overview
Table 119. Bluebird Bio(Pipeline) Recent Developments
Table 120. Cellectis(Pipeline) Basic Information
Table 121. Cellectis(Pipeline) CAR T-Cell Therapy Product Overview
Table 122. Cellectis(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Cellectis(Pipeline) Business Overview
Table 124. Cellectis(Pipeline) Recent Developments
Table 125. Allogene Therapeutics(Pipeline) Basic Information
Table 126. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Overview
Table 127. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Allogene Therapeutics(Pipeline) Business Overview
Table 129. Allogene Therapeutics(Pipeline) Recent Developments
Table 130. Celyad(Pipeline) Basic Information
Table 131. Celyad(Pipeline) CAR T-Cell Therapy Product Overview
Table 132. Celyad(Pipeline) CAR T-Cell Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Celyad(Pipeline) Business Overview
Table 134. Celyad(Pipeline) Recent Developments
Table 135. Global CAR T-Cell Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global CAR T-Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific CAR T-Cell Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific CAR T-Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa CAR T-Cell Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa CAR T-Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global CAR T-Cell Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global CAR T-Cell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global CAR T-Cell Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global CAR T-Cell Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global CAR T-Cell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CAR T-Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell Therapy Market Size (M USD), 2025-2035
Figure 5. Global CAR T-Cell Therapy Market Size (M USD) (2020-2035)
Figure 6. Global CAR T-Cell Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CAR T-Cell Therapy Product Life Cycle
Figure 13. CAR T-Cell Therapy Sales Share by Manufacturers in 2025
Figure 14. Global CAR T-Cell Therapy Revenue Share by Manufacturers in 2025
Figure 15. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CAR T-Cell Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell Therapy Revenue in 2025
Figure 18. Industry Chain Map of CAR T-Cell Therapy
Figure 19. Global CAR T-Cell Therapy Market PEST Analysis
Figure 20. Global CAR T-Cell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CAR T-Cell Therapy Market Share by Type
Figure 27. Sales Market Share of CAR T-Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of CAR T-Cell Therapy by Type in 2025
Figure 29. Market Share of CAR T-Cell Therapy by Type (2020-2025)
Figure 30. Market Share of CAR T-Cell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CAR T-Cell Therapy Market Share by Application
Figure 33. Global CAR T-Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global CAR T-Cell Therapy Sales Market Share by Application in 2025
Figure 35. Global CAR T-Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global CAR T-Cell Therapy Market Share by Application in 2025
Figure 37. Global CAR T-Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global CAR T-Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global CAR T-Cell Therapy Market Size by Region (2020-2025)
Figure 40. North America CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CAR T-Cell Therapy Sales Market Share by Country in 2024
Figure 43. North America CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CAR T-Cell Therapy Market Size by Country in 2024
Figure 45. U.S. CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CAR T-Cell Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CAR T-Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CAR T-Cell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CAR T-Cell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CAR T-Cell Therapy Sales Market Share by Country in 2024
Figure 53. Europe CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CAR T-Cell Therapy Market Size by Country in 2024
Figure 55. Germany CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CAR T-Cell Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CAR T-Cell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific CAR T-Cell Therapy Market Size by Region in 2024
Figure 68. China CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CAR T-Cell Therapy Sales and Growth Rate (K MT)
Figure 79. South America CAR T-Cell Therapy Sales Market Share by Country in 2024
Figure 80. South America CAR T-Cell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America CAR T-Cell Therapy Market Size by Country in 2024
Figure 82. Brazil CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CAR T-Cell Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CAR T-Cell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CAR T-Cell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CAR T-Cell Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CAR T-Cell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CAR T-Cell Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CAR T-Cell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CAR T-Cell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CAR T-Cell Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global CAR T-Cell Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global CAR T-Cell Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of CAR T-Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell Therapy Market Size (M USD), 2025-2035
Figure 5. Global CAR T-Cell Therapy Market Size (M USD) (2020-2035)
Figure 6. Global CAR T-Cell Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CAR T-Cell Therapy Product Life Cycle
Figure 13. CAR T-Cell Therapy Sales Share by Manufacturers in 2025
Figure 14. Global CAR T-Cell Therapy Revenue Share by Manufacturers in 2025
Figure 15. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CAR T-Cell Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell Therapy Revenue in 2025
Figure 18. Industry Chain Map of CAR T-Cell Therapy
Figure 19. Global CAR T-Cell Therapy Market PEST Analysis
Figure 20. Global CAR T-Cell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CAR T-Cell Therapy Market Share by Type
Figure 27. Sales Market Share of CAR T-Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of CAR T-Cell Therapy by Type in 2025
Figure 29. Market Share of CAR T-Cell Therapy by Type (2020-2025)
Figure 30. Market Share of CAR T-Cell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CAR T-Cell Therapy Market Share by Application
Figure 33. Global CAR T-Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global CAR T-Cell Therapy Sales Market Share by Application in 2025
Figure 35. Global CAR T-Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global CAR T-Cell Therapy Market Share by Application in 2025
Figure 37. Global CAR T-Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global CAR T-Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global CAR T-Cell Therapy Market Size by Region (2020-2025)
Figure 40. North America CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CAR T-Cell Therapy Sales Market Share by Country in 2024
Figure 43. North America CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CAR T-Cell Therapy Market Size by Country in 2024
Figure 45. U.S. CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CAR T-Cell Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CAR T-Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CAR T-Cell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CAR T-Cell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CAR T-Cell Therapy Sales Market Share by Country in 2024
Figure 53. Europe CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CAR T-Cell Therapy Market Size by Country in 2024
Figure 55. Germany CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CAR T-Cell Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CAR T-Cell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific CAR T-Cell Therapy Market Size by Region in 2024
Figure 68. China CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CAR T-Cell Therapy Sales and Growth Rate (K MT)
Figure 79. South America CAR T-Cell Therapy Sales Market Share by Country in 2024
Figure 80. South America CAR T-Cell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America CAR T-Cell Therapy Market Size by Country in 2024
Figure 82. Brazil CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CAR T-Cell Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CAR T-Cell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CAR T-Cell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CAR T-Cell Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CAR T-Cell Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CAR T-Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CAR T-Cell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China CAR T-Cell Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CAR T-Cell Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CAR T-Cell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CAR T-Cell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CAR T-Cell Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global CAR T-Cell Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global CAR T-Cell Therapy Market Share Forecast by Application (2026-2035)
